<--GAT-->

How Do Long-Term Heart Failure Patients Differ from Recently-Diagnosed?

by U.S. Medicine

July 28, 2017

DURHAM, NC – How are long-term chronic heart failure (HF) survivors who are hospitalized for acute exacerbation different from patients with more recent HF diagnoses?

A study led by Duke University and involving researchers from the San Francisco VAMC sought to answer that question, evaluating the influence of HF chronicity on acute HF patient profiles and outcomes. The results were published recently in the Journal of the American College of Cardiology.1

The ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) trial randomized 7,141 hospitalized patients with acute HF with reduced or preserved ejection fraction (EF) to receive nesiritide or placebo in addition to standard care.

Researchers compared patients according to duration of HF diagnosis before index hospitalization by using pre-specified cutoffs — 0 to 1 month was defined as “recently diagnosed,” and the other groups were less than one month to a year, more than a year to 60 months and greater than 60 months.

As a whole, 80.4% of the 5,741patients had documentation of duration of HF diagnosis, with the average age ranging 64 to 66 years, and mean ejection fraction varying from 29% to 32%.

Results indicate that, compared with patients with longer HF duration, recently diagnosed patients were more likely to be women with non-ischemic HF etiology, higher baseline blood pressure, better baseline renal function, and fewer comorbidities.

After adjustment, compared with recently diagnosed patients, patients with longer HF duration were associated with more persistent dyspnea at 24 hours and increased 180-day mortality:

  • 1 to 12 months, odds ratio [OR]: 1.20 and hazard ratio [HR]: 1.89, respectively;
  • >12 to 60 months, OR: 1.34 and HR: 1.82, respectively;
  • >60 months, OR: 1.31 and HR 2.02, respectively.

“The influence of HF duration on mortality was potentially more pronounced among female patients (interaction p = 0.05), but did not differ according to age, race, prior ischemic heart disease, or ejection fraction (all interactions, p ≥ 0.23),” the authors noted.

They concluded, “In this acute HF trial, patient profile differed according to duration of the HF diagnosis. A diagnosis of HF for ≤1 month before hospitalization was independently associated with greater early dyspnea relief and improved post-discharge survival compared to patients with chronic HF diagnoses. The distinction between de novo or recently diagnosed HF and worsening chronic HF should be considered in the design of future acute HF trials.”

  1. Greene SJ, Hernandez AF, Dunning A, Ambrosy AP, Armstrong PW, Butler J, Cerbin LP, Coles A, Ezekowitz JA, Metra M, Starling RC, Teerlink JR, Voors AA, O’Connor CM, Mentz RJ. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. J Am Coll Cardiol. 2017 Jun 27;69(25):3029-3039. doi: 10.1016/j.jacc.2017.04.043. PubMed PMID: 28641792.

Comments are closed here.


Related Articles

Million Veteran Program Study Raises Questions about Omega-3 Benefits in CAD

BOSTON—Researchers at the Massachusetts Veterans Epidemiology and Research Information Center demonstrated the value of the VA’s ability to harness the health data of thousands or even millions of individuals in a study that calls into... View Article

No Link Between Anthrax Vaccine, ‘Lone AFib’

ATLANTA—Concerns have been raised about a possible link between receipt of anthrax vaccine adsorbed and atrial fibrillation in military personnel without identifiable underlying risk factors or structural heart disease. A study in Human Vaccines &... View Article


U.S. Medicine Recommends


More From cardiovascular disease

Cardiovascular Disease

Million Veteran Program Study Raises Questions about Omega-3 Benefits in CAD

BOSTON—Researchers at the Massachusetts Veterans Epidemiology and Research Information Center demonstrated the value of the VA’s ability to harness the health data of thousands or even millions of individuals in a study that calls into... View Article

Cardiovascular Disease

CVD Risks Differ by Sex in VA Patients

WASHINGTON—Does the incidence of cardiovascular disease differ by sex among veterans as it does with the general U.S. population? A study in the Journal of Women’s Health sought to answer that question. VA researchers from... View Article

Cardiovascular Disease

PTSD Alone Doesn’t Increase Cardiovascular Risk in Veterans

Study Urges Close Monitoring of Physical, Psychological Co-Morbidities ST. LOUIS—Even though veterans diagnosed with post-traumatic stress disorder are 41% more likely to developing cardiovascular disease than those without, PTSD alone doesn’t fully explain the higher... View Article

Cardiovascular Disease

Current Treatment Halves Cardiovascular Disease Risk in Hep C Patients

PITTSBURGH—In more good news for veterans who have received treatment for hepatitis C virus, VA researchers have found that treatment not only reduces the risk of complications from liver disease, it also dramatically reduces the... View Article

Cardiovascular Disease

Better Sleep Metrics Can Identify CVD Risk in Sleep Apnea

MIAMI—Obstructive sleep apnea (OSA) is known to increase the risk of early mortality, stroke, and cardiovascular disease (CVD). A study published in the journal Frontiers in Neurology noted that OSA is defined by the apnea–hypopnea... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up